United States Biosimilar Drug Market Forecasts to 2021

1
Published June 2016

• United States Biosimilar Drug Industry 2016
  Market Research Report

2
Report Highlights

• Analysis is provided for the international
  markets including development trends, competitive
  landscape analysis, and key regions development
  status
• Development policies and plans are discussed as
  well as manufacturing processes and cost
  structures are also analysed
• The provides key statistics on the state of the
  industry and is a valuable source of guidance and
  direction for companies and individuals
  interested in the market.

3
Report Details

• The United States Biosimilar Drug Industry 2016
  Market Research Report is a professional and
  in-depth study on the current state of the
  Biosimilar Drug industry.
• The report provides a basic overview of the
  industry including definitions, classifications,
  applications and industry chain structure. The
  Biosimilar Drug market analysis is provided for
  the United States markets including development
  trends, competitive landscape analysis, and key
  regions development status.

4
Report Details

• The report focuses on United States major leading
  industry players providing information such as
  company profiles, product picture and
  specification, capacity, production, price, cost,
  revenue and contact information.
• Analysis of Biosimilar Drug Industry Key
  Manufacturers includes Hospira , Sandoz, Teva
  Pharmaceutical Industries, Pfizer, Merck Sharp
  Dohme, Celltrion, Amgen, Biogen, Mylan, Biocon,
  Dr. Reddys Laboratories, Boehringer Ingelheim
  GmbH, Intas Pharmaceuticals, LG Life Sciences,
  Emcure Pharmaceuticals, Probiomed, Biosidus,
  3SBio, WOCKHARDT, Sun Pharmaceutical Industries,
  Shanghai Fosun Pharmaceutical, Qilu
  Pharmaceutical, Allergan, Dongbao, Samsung
  Biologics, Zydus Cadila., Dong-A Pharmaceutical.

View the full Report
5
Table of Contents (Major Points)

1. Industry Overview
2. Manufacturing Cost Structure Analysis of
   Biosimilar Drug
3. Technical Data and Manufacturing Plants Analysis
4. Production Analysis of Biosimilar Drug by
   Regions, Type, and Applications
5. Consumption Volume and Consumption Value
   Analysis of Biosimilar Drug by Regions
6. Analysis of Biosimilar Drug Production, Supply,
   Sales and Market Status 2011-2016
7. Price and Gross Margin Analysis
8. Marketing Trader or Distributor Analysis of
   Biosimilar Drug
9. Development Trend of Biosimilar Drug Industry
   2016-2021
10. Industry Chain Suppliers of Biosimilar Drug with
    Contact Information
11. New Project Investment Feasibility Analysis of
    Biosimilar Drug
12. Conclusion of the United States Biosimilar Drug
    Industry 2016 Market Research Report

Download the Sample Copy
6

• About DecisionDatabases.com

• DecisionDatabases.com is a global business
  research reports provider, enriching decision
  makers and strategists with qualitative
  statistics. DecisionDatabases.com is proficient
  in providing syndicated research report,
  customized research reports, company profiles and
  industry databases across multiple domains.
• Our expert research analysts have been trained to
  map clients research requirements to the correct
  research resource leading to a distinctive edge
  over its competitors. We provide intellectual,
  precise and meaningful data at a lightning speed.
• Email sales_at_decisiondatabases.com
• Web www.decisiondatabases.com
• Contact No 91-9928237112

For any query mail us at sales_at_decisiondatabases.c
om
Order the report United States Biosimilar Drug
Industry 2016 Market Research Report